Moderna, Inc. (NASDAQ:MRNA) ranks among the best biotech stocks to buy. Following solid trial results for Moderna, Inc. (NASDAQ:MRNA)’s refrigerator-stable COVID-19 vaccine, Brookline Capital Markets reaffirmed its Buy rating and $198 price target for the company on September 23. Photo by Ian Hutchinson on Unsplash According to the new data, mNEXSPIKE/mRNA-1283 increased neutralizing antibodies against the LP.8.1 variant by an average of more than sixteen times, which Brookline regarded as “remarkably s ...

Yale economist William Goetzmann says investors are generally too worried about a market crash. His research shows crashes after big surges are rare and often short-lived. Goetzmann advises staying invested long-term for better returns, despite market fears. Yale economist William Goetzmann has felt the fear that a stock-market crash can strike into an investor. He's lived through at least four of them: 1987, 2000, 2008, and 2020. "I watched my entire life savings drop by 50% during the crash of 2 ...